Biopharma contributes to key global health discussions at WHA69
Find out here our take on the 69th World Health Assembly (WHA69) with some key relevant links included!
Read More
Pharmacovigilance of biotherapeutic medicines
A new study released in June 2016 identifying global case studies illustrating successes and challenges. A must read!
Read More
Our response to Zika virus
Check here about the R&D blueprint against Zika
Read More
Women’s Cancer Initiative in the Americas
Partnership to improve prevention of women’s cancers and quality of cancer registries in LAC reaches 1 year milestone
Read More
Latest News
2017-10-03 12:00:25
WIPO and the Research-Based Pharmaceutical Industry Team up to Facilitate Access to Key Medicine Patent Information
GENEVA, 13h00 CET – 3 October 2017 – The World Intellectual Property Organization (WIPO) and the research-based pharmaceutical industry today ...
Read More2017-05-31 18:18:44
IFPMA contribution to key global health discussions @WHA70 (22-31 May 2017)
Geneva, 31 May 2017 – Starting with the election of Dr Tedros Adhanom Ghebreyesus as ...
Read More2017-05-18 13:30:05
New Alliance to Drive and Measure Industry Progress to Curb Antimicrobial Resistance
New Industry Alliance brings together research-based pharmaceutical companies, generics, biotech and diagnostic companies, to drive ...
Read More2017-05-02 07:50:20
Fumie Griego joins International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) as new Assistant Director General
IFPMA Director-General Thomas Cueni announced today that former PhRMA and Merck KGaA executive, Dr Fumie ...
Read More2017-04-17 18:00:39
Progress report on biopharmaceutical industry contributions to the global fight against Neglected Tropical Diseases (NTDs)
109 active R&D projects for NTDs, of which over 90% are collaborative involving over 50 ...
Read More2017-03-09 16:32:44
EBE, EFPIA and IFPMA have today launched a position paper entitled “Considerations for physicians on switching decisions regarding biosimilars”.
Switching describes a physician’s decision to exchange one product that a patient receives for another. ...
Read More2017-02-28 07:57:57
IFPMA launches new policy principles and report on Rare Disease Day 2017 to benefit patients, healthcare and society
New set of policy principles outlines critical elements for a global framework on rare disease ...
Read More
Latest Statement
2017-10-13 08:31:02
Contribution to the public web-based consultation on the Draft concept note towards WHO’s 13th General Programme of Work 2019–2023
IFPMA Comments as a contribution to the public web-based consultation onthe Draft concept note towards WHO’s 13th General Programme of ...
Read More2017-10-12 08:28:56
IFPMA-EFPIA Statement - Global call for action on drug-resistant infections, 12-13 October 2017, Berlin (Conference organized by Wellcome Trust)
New set of policy principles outlines critical elements for a ...
Read More2017-10-12 08:25:01
AMR Industry Alliance Statement - Global call for action on drug-resistant infections, 12-13 October 2017, Berlin (Conference organized by Wellcome Trust)
New set of policy principles outlines critical elements for a ...
Read More2017-10-05 16:00:53
IFPMA Statement at WIPO 2017 General Assemblies
New set of policy principles outlines critical elements for a ...
Read More2017-08-30 16:15:35
IFPMA Statement on UHC at 67th Session of the WHO Regional Committee for Africa
New set of policy principles outlines critical elements for a ...
Read More2017-08-30 14:33:29
IFPMA Statement on Yellow Fever at 67th Session of the WHO Regional Committee for Africa
New set of policy principles outlines critical elements for a ...
Read More2017-06-06 21:37:25
IFPMA Statement to New Essential Medicines List
New set of policy principles outlines critical elements for a ...
Read More
mailto:s.kaenzig@ifpma.org +41 22 338 32 49
direct line
Twitter skaenzig
Sadia Kaenzig - Communications Manager
Sadia manages communications on issues including regulatory, intellectual property protection, trade and the economic footprint of the research-based pharmaceutical industry, research and development ecosystem and innovation, vaccines including influenza vaccines, and biotherapeutics.
mailto:m.depol@ifpma.org +41 22 338 32 20
direct line
Twitter @MorganePol
Morgane De Pol - Communications and Public Affairs
Morgane manages communications on issues including the research-based pharmaceutical industry’s commitment to achieving sustainable and inclusive development, advancing Universal Health Coverage, designing transformational partnerships to build healthier societies, boosting innovation for neglected tropical diseases, expanding access to high quality treatments for infectious and chronic diseases, fighting counterfeit medicines, and promoting resilient and efficient health systems.
Our Brouchure
2015 Edition
A shared commitment to global health
At IFPMA we advocate policies and practices that encourage the discovery of and access to life-saving and life-enhancing medicines and vaccines, for people everywhere.
Our Logo
Full colour EPS format
Our Logo
Full colour PNG format
FULL Name LOGO
Full colour EPS format
FULL Name LOGO
Full colour PNG format
Hot Topic
Pharmacovigilance: Do your bit, play your part!
Pharmacovigilance is one of the key steps to ensuring the safety of all our medicines, including biotherapeutics and vaccines. It encourages an ongoing cycle of communication between patients, health professionals, regulatory authorities, and our biopharma industry which is
Read MoreInterview
IFPMA 2015 interview series 'Biodiversity, human health, and pharma'
A must-watch: Dr Manisha A. Desai, assistant general patent counsel at Eli Lilly and Company, gives her take on the importance of the Convention of Biodiversity and the Nagoya Protocol for the pharma industry. What's key is to
Read MoreOur Blog
Adversity is the mother of invention
This blog was first published on Devex on 10 October 2017 Almost 20 years ago, in 1998, 39 leading pharmaceutical companies sued the South African government to stop legislation on parallel imports and generic substitution. It was one of the dumbest things the industry ever did. What started as a technical legal battle became a public relations disaster of unprecedented magnitude for the industry. The...
Read More
What’s the score? Universal health coverage goals discussed in New York
The headlines were about North Korea, warmongering, sanctions and, well, diplomacy. But this year’s UN General Assembly in New York in truth devoted far more time to sustainable development, climate change, mass migration and poverty – and how to provide universal health care (UHC), including for the 400 million who lack access to essential services such as immunization, family planning and even basic hospital care....
Read More
What you need to know about dementia so that you don’t forget
September is World Alzheimer’s Month, an international campaign to challenge the stigma that surrounds dementia, a disease that affects almost 150,000 people in Switzerland. It is the third most frequent cause of death in the country, costing over CHF 7 billion a year – and as many as 400,000 predominantly elderly Swiss people may live with it by 2040. More than 27,000 Swiss are newly...
Read MoreLatest Tweets
@IFPMA @IFPMA @IFPMA @IFPMA @IFPMA 